167 related articles for article (PubMed ID: 37980520)
21. External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging.
Soeterik TFW; Hueting TA; Israel B; van Melick HHE; Dijksman LM; Stomps S; Biesma DH; Koffijberg H; Sedelaar M; Witjes JA; van Basten JA
BJU Int; 2021 Aug; 128(2):236-243. PubMed ID: 33630398
[TBL] [Abstract][Full Text] [Related]
22. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients.
Hueting TA; Cornel EB; Somford DM; Jansen H; van Basten JA; Pleijhuis RG; Korthorst RA; van der Palen JAM; Koffijberg H
Eur Urol Oncol; 2018 Oct; 1(5):411-417. PubMed ID: 31158080
[TBL] [Abstract][Full Text] [Related]
23. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.
Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ
Eur Urol Oncol; 2023 Dec; 6(6):553-563. PubMed ID: 37045707
[TBL] [Abstract][Full Text] [Related]
24. The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer.
Doan P; Katelaris A; Scheltema MJ; Hayen A; Amin A; Siriwardana A; Tran M; Geboers B; Gondoputro W; Haynes AM; Matthews J; Delprado W; Stricker PD; Thompson J
BMC Urol; 2023 Apr; 23(1):68. PubMed ID: 37118731
[TBL] [Abstract][Full Text] [Related]
25. Rational use of Ga-68 PSMA PET-CT according to nomograms and risk groups for the detection of lymph node metastasis in prostate cancer.
Madendere S; Kılıç M; Köseoğlu E; Aykanat İC; Eden AB; Coşkun B; Tekkalan FB; Balbay MD
Urol Oncol; 2024 Feb; 42(2):29.e9-29.e15. PubMed ID: 38114351
[TBL] [Abstract][Full Text] [Related]
26. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
[TBL] [Abstract][Full Text] [Related]
27. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
[TBL] [Abstract][Full Text] [Related]
28. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
[TBL] [Abstract][Full Text] [Related]
29. External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients.
Peilleron N; Seigneurin A; Herault C; Verry C; Bolla M; Rambeaud JJ; Descotes JL; Long JA; Fiard G
World J Urol; 2021 May; 39(5):1489-1497. PubMed ID: 32583038
[TBL] [Abstract][Full Text] [Related]
30. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
31. Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection.
Li Z; Huang Y; Zhao D; Luo X; Wu Z; Zheng X; Xie Y; Liu Y; Wu J; Peng Y; Li Y; Zhou F
Front Oncol; 2023; 13():1186319. PubMed ID: 37223684
[TBL] [Abstract][Full Text] [Related]
32. Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
de Barros HA; Remmers S; Luiting HB; van Leenders GJLH; Roobol MJ; Bekers EM; Amin A; Haynes AM; Delprado W; Stricker PD; van der Poel HG; van der Kwast TH; van Leeuwen PJ
Urology; 2022 Oct; 168():156-164. PubMed ID: 35803346
[TBL] [Abstract][Full Text] [Related]
33. The Establishment of New Thresholds for PLND-Validated Clinical Nomograms to Predict Non-Regional Lymph Node Metastases: Using
Jiao J; Quan Z; Zhang J; Wen W; Qin J; Yang L; Meng P; Jing Y; Ma S; Wu P; Han D; Davis AA; Ren J; Yang X; Kang F; Zhang Q; Wang J; Qin W
Front Oncol; 2021; 11():658669. PubMed ID: 33937073
[TBL] [Abstract][Full Text] [Related]
34. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
[TBL] [Abstract][Full Text] [Related]
35. Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram.
Kazzazi A; Djavan B
Can J Urol; 2011 Apr; 18(2):5585-91. PubMed ID: 21504645
[TBL] [Abstract][Full Text] [Related]
36. Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5.
Porpiglia F; Manfredi M; Mele F; Bertolo R; Bollito E; Gned D; De Pascale A; Russo F; Passera R; Fiori C; De Luca S
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):85-91. PubMed ID: 29472629
[TBL] [Abstract][Full Text] [Related]
37. External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer.
Milonas D; Venclovas Z; Muilwijk T; Jievaltas M; Joniau S
Cent European J Urol; 2020; 73(1):19-25. PubMed ID: 32395318
[TBL] [Abstract][Full Text] [Related]
38. External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era.
Frego N; Paciotti M; Buffi NM; Maffei D; Contieri R; Avolio PP; Fasulo V; Uleri A; Lazzeri M; Hurle R; Saita A; Guazzoni GF; Casale P; Lughezzani G
Front Surg; 2022; 9():829515. PubMed ID: 35284478
[TBL] [Abstract][Full Text] [Related]
39. First Nomogram Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients Undergoing Radioisotope Guided Sentinel Lymph Node Dissection.
Winter A; Kneib T; Rohde M; Henke RP; Wawroschek F
Urol Int; 2015; 95(4):422-8. PubMed ID: 26159232
[TBL] [Abstract][Full Text] [Related]
40. Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomy.
Abdollah F; Klett DE; Sammon JD; Dalela D; Sood A; Hsu L; Diaz M; Gupta N; Peabody JO; Trinh QD; Menon M
Can J Urol; 2016 Feb; 23(1):8141-50. PubMed ID: 26892054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
